home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

EACR Next Generation Cancer Therapies

 
  April 25, 2024  
     
 
The European Association for Cancer Research (EACR), Virtual event, online
24-25 September 2024


This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients.

The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development.

Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.

 
 
Organized by: The European Association for Cancer Research (EACR)
Invited Speakers:

Alessio Ciulli | Ecaterina Dumbrava | Puja Sapra | Jan Smith | Nicolas Thoma

 
Deadline for Abstracts: 29 July 2024
 
Registration:

Registration deadline: 09 September 2024

E-mail: hannah.barrs@eacr.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.